Growth Metrics

Vycor Medical (VYCO) Accumulated Expenses (2010 - 2026)

Vycor Medical (VYCO) reported Accumulated Expenses of $90953.0 for Q1 2026, down 59.21% year-over-year from $222966.0 in Q1 2025, and up 1.13% on a QoQ basis from $89938.0 in Q4 2025.

Vycor Medical (VYCO) has 17 years of Accumulated Expenses data on file, last reported at $90953.0 in Q1 2026.

  • Quarterly Accumulated Expenses fell 59.21% year-over-year to $90953.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90953.0 (down 59.21% YoY) and the FY2025 annual result came in at $89938.0, down 42.91% from the prior year.
  • Accumulated Expenses grew to $90953.0 in Q1 2026 per VYCO's latest filing, from $89938.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $544833.0 in Q2 2025 and bottomed at $89938.0 in Q4 2025.
  • The 5-year median for Accumulated Expenses is $401779.0 (2022), against an average of $330513.6.
  • The widest annual swing landed in 2023, when Accumulated Expenses surged 223.89%; it then sank 66.69% in 2024.
  • Tracing VYCO's Accumulated Expenses over 5 years: stood at $146007.0 in 2022, then surged by 223.89% to $472897.0 in 2023, then slumped by 66.69% to $157545.0 in 2024, then tumbled by 42.91% to $89938.0 in 2025, then increased by 1.13% to $90953.0 in 2026.
  • Per Business Quant, the three latest VYCO Accumulated Expenses figures stand at $90953.0 (Q1 2026), $89938.0 (Q4 2025), and $127231.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Vycor Medical - - 375,153.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 90,953.00
Dec 31, 2025 89,938.00
Sep 30, 2025 127,231.00
Jun 30, 2025 544,833.00
Mar 31, 2025 532,866.00
Dec 31, 2024 157,545.00
Sep 30, 2024 508,931.00
Jun 30, 2024 496,833.00
Mar 31, 2024 484,866.00
Dec 31, 2023 195,522.00
Sep 30, 2023 183,087.00
Jun 30, 2023 170,651.00
Mar 31, 2023 436,732.00
Dec 31, 2022 424,897.00
Sep 30, 2022 413,091.00
Jun 30, 2022 401,779.00
Mar 31, 2022 390,599.00
Dec 31, 2021 380,479.00
Sep 30, 2021 369,168.00
Jun 30, 2021 358,677.00
Mar 31, 2021 345,015.00
Dec 31, 2020 328,897.00
Dec 31, 2019 280,765.00
Mar 31, 2018 112,500.00
Dec 31, 2017 225,000.00
Sep 30, 2017 112,500.00
Mar 31, 2017 82,500.00
Dec 31, 2016 446,957.00
Sep 30, 2016 234,721.00
Jun 30, 2016 258,264.00
Mar 31, 2016 273,994.00
Dec 31, 2015 243,620.83
Mar 31, 2015 315,876.00
Dec 31, 2014 401,105.31
Sep 30, 2014 352,755.00
Jun 30, 2014 278,743.00
Mar 31, 2014 325,244.00
Dec 31, 2013 1.84 Mn
Sep 30, 2013 1.55 Mn
Jun 30, 2013 1.39 Mn
Mar 31, 2013 1.27 Mn
Dec 31, 2012 1.20 Mn
Sep 30, 2012 155,982.00
Jun 30, 2012 980,807.00
Mar 31, 2012 88,651.00
Dec 31, 2011 754,895.00
Sep 30, 2011 658,098.00
Jun 30, 2011 514,934.00
Dec 31, 2010 406,998.00